Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Moleculomics logo — Working molecular knowledge across genomes

Moleculomics

Working molecular knowledge across genomes

Founded 2012 United Kingdom Swansea, United Kingdom 1 employees Biotechnology

General Information

Company Name Moleculomics
Founded Year 2012
Location United Kingdom Swansea, United Kingdom +1
Employees 1
Industries Biotechnology
Social

Get notified when Moleculomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Moleculomics

Moleculomics is a biotechnology startup dedicated to revolutionizing the life sciences industry with its in silico modeling of genome-scale protein structure, ligand docking, and protein-protein interactions. Founded in 2012, Moleculomics has leveraged artificial intelligence and computational technologies to drive innovations in drug discovery, toxicity screening, and precision medicine. Their R&D efforts, underpinned by a substantial track record with over 70 journal publications, have resulted in groundbreaking platform technologies and services that are unparalleled in scope and algorithmic sophistication. The company's fervent dedication is evident in its commercial R&D programs, collaborating with global partners on prestigious projects that encompass Hit-to-Lead and toxicity screening work. Moleculomics' offerings are encapsulated in their Human3DProteome.com platform, showcasing a diverse array of in silico technologies. As the company continues to make significant strides in the field, its impact on the pharmaceutical, health, and biotech sectors is increasingly becoming undeniable. With its commitment to cutting-edge research and technology, Moleculomics is poised to play a pivotal role in shaping the future of the life sciences industry, making it an intriguing prospect for potential venture capital investment.

Taxonomy: Life Science Technology, Genome Scale Modeling, Protein Structure Prediction, Ligand Docking, Protein-Protein Interactions, Drug Discovery, Toxicity Screening, Precision Medicine, Computational Technologies, Biosimulation Tools, Data Resources, In Silico Lead Discovery, Pathway Analysis, Bioinformatics Technologies

No funding data available for Moleculomics yet.

Get notified when Moleculomics raises funding

Moleculomics Alternatives & Competitors

Moleculomics vs
NovaMechanics Ltd
NovaMechanics Ltd Cyprus

Cheminformatics Nanoinformatics Isalos Analytics Platform Enalos Cloud Platform

21 employees
Analytics, Biotechnology
Moleculomics vs
SilicoGenesis
SilicoGenesis Belgium

Develop better antibodies faster with our AI-enabled in silico antibody engineering platform.

4 employees
Biotechnology
Moleculomics vs
Creative Biostructure
Creative Biostructure United States

Our Mission is to Develop Creative Structure-based Therapies

201-500 employees
Biopharma, Biotechnology

FAQ About Moleculomics

Working molecular knowledge across genomes
Moleculomics was founded in 2012.
Moleculomics is headquartered in Swansea, United Kingdom.
Moleculomics operates in the following industries: Biotechnology.
Moleculomics has approximately 1 employees.
Top alternatives and competitors to Moleculomics include NovaMechanics Ltd, SilicoGenesis, Creative Biostructure, ZoBio, OTAVA Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Moleculomics and NovaMechanics Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Moleculomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy